Clinical and pathologic indexes | Â | High NLRX1 | Low NLRX1 | Â | ||
---|---|---|---|---|---|---|
 | n = 382 | % | n = 193 | % | P | |
Age, years | ≤ 50 | 149 | 36.3 | 70 | 33.7 | 0.586 |
> 50 | 293 | 63.7 | 123 | 66.3 |  | |
Gender | Male | 382 | 86.5 | 167 | 86.4 | 1.000 |
Female | 60 | 13.5 | 26 | 13.6 | Â | |
HBsAg | Negative | 87 | 28.0 | 54 | 19.7 | 0.023 |
Positive | 355 | 72.0 | 139 | 80.3 | Â | |
With liver cirrhosis | No | 7 | 1.60 | 3 | 1.60 | 1.000 |
Yes | 435 | 98.4 | 190 | 98.4 | Â | |
GGT (U/L) | ≤ 54 | 141 | 31.1 | 60 | 31.9 | 0.853 |
> 54 | 301 | 68.9 | 133 | 68.1 |  | |
AFP (ng/mL) | ≤400 | 280 | 50.8 | 98 | 63.3 | 0.004 |
> 400 | 162 | 49.2 | 95 | 36.7 |  | |
Tumor number | Single | 323 | 75.6 | 146 | 73.1 | 0.556 |
Multiple | 119 | 24.4 | 47 | 26.9 | Â | |
Tumor size, cm | ≤ 5 | 216 | 40.9 | 79 | 48.9 | 0.070 |
> 5 | 226 | 59.1 | 114 | 51.1 |  | |
Tumor encapsulation | Complete | 219 | 56.0 | 108 | 49.5 | 0.143 |
None | 223 | 44.0 | 85 | 50.5 | Â | |
Edmondson stage | I-II | 333 | 62.7 | 121 | 75.3 | 0.002 |
II-IV | 109 | 37.3 | 72 | 24.7 | Â | |
BCLC stage | 0-A | 279 | 77.1 | 111 | 77.1 | 1.000 |
B-C | 83 | 22.9 | 33 | 22.9 | Â | |
PVTT | None | 278 | 48.2 | 93 | 62.9 | 0.010 |
Yes | 164 | 51.8 | 100 | 37.1 | Â |